Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.140
-0.050 (-1.57%)
Oct 29, 2025, 3:36 PM EDT - Market open
Grace Therapeutics Employees
Grace Therapeutics had 6 employees as of March 31, 2025. The number of employees increased by 2 or 50.00% compared to the previous year.
Employees
6
Change (1Y)
2
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,718,833
Market Cap
43.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | 11 | 4 | 57.14% |
| Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GRCE News
- 6 days ago - Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review - GlobeNewsWire
- 5 weeks ago - Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting - GlobeNewsWire
- 5 weeks ago - Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104 - GlobeNewsWire
- 7 weeks ago - Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104 - GlobeNewsWire
- 2 months ago - Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update - GlobeNewsWire
- 4 months ago - Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 - GlobeNewsWire
- 4 months ago - Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update - GlobeNewsWire